Parkinson’s Disease Therapeutics
1st Edition
Emphasis on Nanotechnological Advances
Secure Checkout
Personal information is secured with SSL technology.Free Shipping
Free global shippingNo minimum order.
Description
Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances presents the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics. Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases.
Key Features
- Emphasizes novel therapeutics for Parkinson’s disease, including nanotechnology, natural products and antioxidants
- Discusses the pros and cons of recently developed therapy options for Parkinson's
- Focuses on the efficacy of nanotechnology in overcoming the blood-brain barrier and biomaterial design
Readership
Neuroscientists, biomedical researchers and graduate and medical students
Table of Contents
1. Introduction: Parkinson’s Disease Pathology and Therapeutics
2. Biomaterials: A Boon or a Bane in the Treatment of Parkinson’s Disease
3. Blood Brain Barrier
4. Natural Compounds in the Treatment of Parkinson’s Disease
5. Curcumin: A Promising Therapeutic in Parkinson’s Disease Treatment
6. Redox Nanoparticles: The Corner Stones in the Development of Parkinson’s Disease Therapeutics
7. Liposomal Maneuvers against Parkinson’s Disease
8. Nasal Delivery Nanoparticles: An Insight into Novel Parkinson’s Disease Therapeutics
9. α-Synuclein Targeted Nanoparticles
10. Pros and Cons of Parkinson’s Disease Therapeutics
Details
- No. of pages:
- 146
- Language:
- English
- Copyright:
- © Academic Press 2020
- Published:
- 3rd February 2020
- Imprint:
- Academic Press
- Paperback ISBN:
- 9780128198827
- eBook ISBN:
- 9780128198834
About the Author
Magisetty Obulesu
Magisetty Obulesu is a research associate in University of Tsukuba, Tsukuba, Japan. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer’s disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer’s disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu’s present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.
Affiliations and Expertise
University of Tsukuba, Tsukuba, Japan
Ratings and Reviews
Request Quote
Tax Exemption
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.